
The Hong Kong stock biotechnology sector collectively weakened, with QYUNS-B and LEADS BIOLABS-B falling over 10%
The Hong Kong stock biotechnology sector collectively weakened, with QYUNS-B and LEADS BIOLABS-B falling over 10%, while RemeGen, JUNSHI BIO, and WuXi BIO all declined

